Inebilizumab llega a México tras aprobación de Cofepris como nueva terapia para el trastorno de la neuromielitis óptica ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback